The Role of Phytochemicals in Age-Related Cognitive Decline: A Natural Solution for Brain Health

Abstract

Age-related cognitive decline, characterized by memory loss, attention deficits, and reduced executive function, remains a major public health challenge, with limited pharmaceutical interventions offering symptomatic relief. Phytochemicals, bioactive compounds derived from plants, have emerged as promising neuroprotective agents due to their antioxidant, anti-inflammatory, and neurogenic properties. This review explores the role of phytochemicals in mitigating cognitive deterioration through in vitro, in vivo, and clinical studies. Key compounds such as flavonoids, curcumin, resveratrol, and Ginkgo biloba derived compounds including; Ginkgolic Acids, terpenoids (Ginkgolides and Bilobalide), have demonstrated potential in reducing oxidative stress, modulating neuroinflammation, enhancing mitochondrial function, and improving neurotransmitter balance. However, challenges such as bioavailability, dose optimization, and clinical translation hinder their widespread adoption. Advances in delivery technologies, including nanoencapsulation and liposomal formulations, may enhance their therapeutic efficacy. Additionally, integrative strategies combining phytochemical-rich diets with lifestyle interventions, such as the Mediterranean and MIND diets, present a holistic approach to cognitive health. While preliminary findings are promising, further large-scale clinical trials are needed to validate the efficacy of phytochemicals in preventing and treating age-related cognitive decline. Understanding their mechanisms and overcoming translational barriers will facilitate their integration into mainstream healthcare as sustainable, natural alternatives to pharmacological treatments. By leveraging the neuroprotective potential of phytochemicals, future interventions could provide accessible and effective solutions for promoting brain health in aging populations.

Introduction

As the global population ages, age-related cognitive decline has emerged as a significant public health concern. Cognitive impairments, such as memory loss, attention deficits, and diminished executive function, are commonly observed in the elderly, often culminating in conditions like Alzheimer's disease, Parkinson disease, and other forms of dementia which not only impair individual quality of life but also place an enormous burden on healthcare systems worldwide. ¹ The current pharmaceutical interventions, while helpful, often come with limited efficacy, side effects, and a lack of long-term solutions, highlighting the urgent need for alternative, effective, and accessible strategies for managing cognitive decline. ² In recent years, attention has shifted toward natural compounds, particularly phytochemicals, as potential allies in promoting brain health and mitigating cognitive decline. ³ Phytochemicals are bioactive compounds found in plants and have been shown to exert various protective effects on the brain, offering a promising natural solution to an aging population. With their antioxidant, anti-inflammatory, and neurogenic properties, these compounds have garnered increasing interest for their ability to counteract the key molecular processes that drive age-related cognitive deterioration. ⁴ However, despite this growing body of evidence, the full therapeutic potential of phytochemicals for cognitive health remains underexplored and not well-integrated into mainstream clinical practice. ⁵ Given the limitations of existing treatments and the expanding scientific interest in plant-based interventions, it is essential to explore the role of phytochemicals in combating age-related cognitive decline. Understanding their mechanisms of action, identifying the most beneficial compounds, and addressing challenges in bioavailability and clinical application will pave the way for developing natural, affordable, and sustainable alternatives to manage cognitive aging. This study aims to fill the gap by providing a comprehensive review of the neuroprotective properties of phytochemicals, their current research status, and the potential for their integration into future cognitive health strategies. By focusing on natural solutions, this research could contribute to developing preventive measures and therapeutic options that promote brain health and enhance the quality of life for aging populations. This review explores the role of phytochemicals in age-related cognitive decline, focusing on their mechanisms of action, key compounds with neuroprotective effects, and the challenges in translating this knowledge into practical applications. As research continues to unfold, phytochemicals may provide a vital piece of the puzzle in developing accessible and sustainable strategies for preserving brain health in aging populations. This study is a modest contribution to existing scientific literature on the neuroprotective effects of phytochemicals which integrates mechanisms with clinical implication. It discusses the synergistic effects of phytochemicals, such as oxidative stress reduction, inflammation modulation, and neurogenesis, to combat age-related cognitive decline. More so, most current literature primarily focuses on specific neurodegenerative diseases like Alzheimer's or Parkinson's disease when discussing cognitive decline. In contrast, this study expands the scope by considering age-related cognitive decline as a multifactorial process, addressing the broader spectrum of cognitive impairments that occur with aging. This allows for a more comprehensive understanding of how phytochemicals may support brain health across a range of age-related cognitive conditions, not just those diagnosed as clinical neurodegenerative diseases.

Methodology

This review employed a thorough approach to explore the neuroprotective role of phytochemicals in mitigating age-related cognitive decline. Comprehensive literature searches were conducted using databases such as PubMed, Scopus, and Web of Science, focusing on peer-reviewed articles published in the last decade. Keywords included “phytochemicals,” “cognitive decline,” “neuroprotection,” “oxidative stress,” “neuroinflammation,” and “age-related cognitive impairment.” Studies were selected based on their relevance, scientific rigor, and inclusion of mechanisms of action, clinical outcomes, or challenges associated with phytochemical use. The search prioritized identifying key phytochemicals (eg, flavonoids, curcumin, resveratrol), their sources, mechanisms of action, and clinical implications. Evidence from in vitro, in vivo, and clinical studies was integrated to provide a comprehensive overview of their effects on oxidative stress, inflammation, mitochondrial function, neurotransmitter regulation, and synaptic plasticity. Challenges such as bioavailability and absorption were addressed by reviewing advancements in delivery technologies. The review synthesized findings to highlight the therapeutic potential of phytochemicals and identified gaps in current research, suggesting future directions for integrating these compounds into cognitive health strategies. All findings were presented and discussed simultaneously.

Understanding Age-Related Cognitive Decline

Age-related cognitive decline is a natural process that typically affects older adults, manifesting as a gradual reduction in memory, learning, and other cognitive functions. ⁶ While cognitive decline is a normal aspect of aging, it can range from mild, non-pathological changes to more severe conditions such as mild cognitive impairment (MCI) and dementia, including Alzheimer's disease (AD). Figure 1 is an illustration of a cognitively declined brain compared to a normal healthy brain, indication various processes leading to brain degeneration., and possible therapeutic interventions that can mitigate the deleterious effects including pharmacological treatments for cognitive decline which offer symptom relief but have limitations, and phytochemicals provide a promising, multi-targeted, and holistic alternative. The impact of these conditions is profound, not only on individuals but also on families, caregivers, and healthcare systems worldwide. ⁷ The primary mechanisms underlying cognitive decline are complex and multifactorial, involving a combination of genetic, environmental, and lifestyle factors. ⁸ However, several key neurobiological processes have been identified as central contributors to the decline in cognitive function as we age:

Oxidative Stress : Oxidative stress occurs when the reactive oxygen species levels surpass the endogenous defense systems leading to damage of proteins, lipids, and DNA. ⁹ With aging, the body's ability to neutralize reactive oxygen species (ROS) diminishes, leading to oxidative damage to brain cells. This oxidative stress can damage neurons, disrupt synaptic plasticity, and impair cognitive performance. ¹⁰

Chronic Inflammation : Inflammation in the brain, often referred to as neuroinflammation, plays a critical role in the development of cognitive decline. Aging is associated with a low-grade, chronic inflammatory state that can lead to the activation of microglia, the brain's immune cells, which in turn contribute to neuronal injury and cognitive deficits. ¹¹

Mitochondrial Dysfunction : Mitochondria are essential for energy production in cells, including neurons. ¹² As we age, mitochondrial function deteriorates, leading to reduced ATP production, increased ROS production, and neuronal damage. This dysfunction is closely linked to the pathogenesis of cognitive decline and neurodegenerative diseases. ¹³

Neurotransmitter Imbalance : Aging is associated with changes in neurotransmitter systems, particularly those involving acetylcholine, dopamine, and glutamate. These imbalances can affect memory, learning, and other cognitive functions. ¹⁴

Figure 1.

Therapeutic Strategies for Age-Related Cognitive Decline: Targeting Oxidative Stress, Inflammation, and Mitochondrial Dysfunction for Neuroprotection (Created in BioRender.com). Therapeutic Interventions can Reverse These Negative Biochemical Impacts as Indicated by the Arrow to Normal Brain Tissues.

Memory and Learning in Age-Related Cognitive Decline

Natural aging often leads to deterioration of memory together with learning abilities as people get older. ¹⁵ Brain structural and functional abnormalities become noticeable with aging since the hippocampus and prefrontal cortex specifically regulate memory creation and manage executive functions. ¹⁶ Working memory declines as a major consequence of cognitive aging and this causes problems for processing and maintaining information during active operation. Specific memory events known as episodic memory show the most impact in long-term memory storage. ¹⁷ The knowledge base of procedural and semantic memory types does not experience substantial decline even though cognitive aging has other impacts on memory.

Brain atrophy through age-related processes causes the brain to shrink and reduce its total volume throughout its structure. The hippocampus shows special vulnerability because it shrinks rapidly which interferes with new memory creation. ¹⁸ The effectiveness of brain regions to exchange neural signals is reduced because white matter integrity decreases.^19,20 Learning ability becomes impaired through prefrontal cortex neuronal loss which combines with synaptic degradation of this brain region that executes executive functions. The functional decline from aging results in decreased neurotransmitter levels of acetylcholine and dopamine along with symptoms that reduce cognitive performance and learning.^21,22 As synaptic plasticity decreases the brain becomes less able to change and create new neural pathways hence learning tasks become more difficult. ²³ Poor blood circulation in the brain during aging causes reduced oxygen delivery and nutritional deficiencies that disable cognitive performance.

Brain learning abilities decrease as people age because of lower information processing speed alongside diminished synaptic plasticity. ²⁴ New knowledge acquisition requires both additional time and multiple replications for older adults to learn effectively. Learning challenges are worsened by diminished attention abilities especially when it comes to spreading attention between different tasks.^25,26 Even with these changes people do not necessarily experience cognitive decline. People can sustain their cognitive functioning through mental challenges and regular exercise and social activities combined with proper nutrition according to research.^27,28 Memory retention and learning in older adults can benefit from incremental approaches to learning combined with memory aids in addition to structured learning environments. ²⁹

Current Pharmacological and Emerging Phytochemical Approaches to Combat Age-Related Cognitive Decline

Currently, the primary therapeutic approaches to combat age-related cognitive decline are pharmacological interventions aimed at managing symptoms and slowing disease progression. In the case of Alzheimer's disease and other dementias, the most commonly prescribed drugs include cholinesterase inhibitors (eg, donepezil, rivastigmine) and N-methyl D-aspartate (NMDA) receptor antagonists (eg, memantine). ³⁰ These medications work by either increasing the levels of acetylcholine in the brain or regulating glutamate activity, both of which are involved in cognitive function. ³⁰ However, these treatments provide only modest improvements in cognition and do not address the underlying causes of cognitive decline. Additionally, they are often associated with side effects such as gastrointestinal issues, dizziness, and confusion. ² Another promising avenue involves disease-modifying therapies (DMTs) that target the biological hallmarks of neurodegenerative diseases, such as amyloid plaques and tau tangles in Alzheimer's disease. ³¹ Drugs like anti-amyloid monoclonal antibodies (eg, aducanumab, lecanemab) have shown some potential in reducing amyloid burden, but their clinical efficacy has been debated, with mixed results in terms of improving cognition or delaying progression. ³² These therapies are also expensive and can have significant side effects, such as brain swelling or bleeding. Despite advances, these pharmacological treatments are largely symptomatic and often fail to halt or reverse the progression of cognitive decline. Moreover, they do not address other contributing factors, such as oxidative stress, neuroinflammation, or mitochondrial dysfunction, which are key in the aging brain. ³³ This highlights the need for alternative or complementary therapies, such as those involving natural compounds like phytochemicals, which may offer a more holistic approach to brain health by targeting multiple mechanisms simultaneously. As a result, there is growing interest in exploring alternative, non-pharmacological interventions that can prevent or delay cognitive decline, with a particular emphasis on natural compounds. Thus, phytochemicals, due to their wide-range of bioactivity, are emerging as a promising avenue to counteract the underlying mechanisms of cognitive aging. These naturally occurring plant compounds may help mitigate oxidative stress, ³⁴ reduce inflammation, ³⁵ and support neuronal health, offering a holistic approach to preserving cognitive function as we age. ³⁶

Phytochemicals: A Potential Solution for Brain Health

Phytochemicals, the bioactive compounds found in plants, have gained significant attention as a promising natural solution for promoting brain health and mitigating age-related cognitive decline. These compounds are abundant in fruits, vegetables, herbs, and other plant-based foods, and they exhibit diverse biochemical activities that can address key mechanisms implicated in cognitive aging. ⁴ Importantly, phytochemicals are accessible, cost-effective, and typically associated with fewer side effects than synthetic drugs, ³⁷ making them a practical option for supporting cognitive health in aging populations. While they cannot completely replace conventional therapies, their ability to target multiple aspects of brain health makes them an attractive complementary approach. Unlike conventional pharmacological therapies that often target a single pathway, phytochemicals offer the advantage of acting on multiple pathways simultaneously, making them well-suited for tackling the complex nature of brain aging. ³⁸ The neuroprotective potential of phytochemicals can be attributed to their wide range of beneficial properties as explained below and summarized in Figure 2.

Figure 2.

Phytochemicals and Brain Health: A Multi-Pathway Approach to Cognitive Protection (Created in https://BioRender.com).

Antioxidant Activity : Oxidative stress, resulting from an imbalance between reactive oxygen species (ROS) and the body's antioxidant defenses, is a major contributor to neuronal damage. ³⁹ Phytochemicals are renowned for their ability to scavenge free radicals and reduce oxidative stress, which is a major contributor to neuronal damage in aging. ⁴⁰ Compounds such as flavonoids, polyphenols, and carotenoids help neutralize reactive oxygen species, ⁴¹ protecting neurons from oxidative damage and maintaining cellular integrity. ³⁹ This protection preserves neuronal integrity, prevents lipid peroxidation, and supports synaptic plasticity, which is vital for memory and learning. ⁴

Anti-inflammatory Effects : Chronic neuroinflammation, driven by activated microglia and elevated pro-inflammatory cytokines, is a hallmark of cognitive decline and neurodegenerative diseases. ⁴² Phytochemicals such as curcumin and resveratrol suppress the activation of inflammatory pathways, including nuclear factor-kappa B (NF-κB) and cyclooxygenase enzymes, thereby reducing inflammation and protecting neurons. ⁴³

Support for Neurogenesis and Synaptic Plasticity : Phytochemicals enhance the brain's ability to generate new neurons (neurogenesis) and form new synaptic connections (synaptic plasticity), processes critical for learning and memory. ⁴⁴ For example, flavonoids in berries and cocoa stimulate brain-derived neurotrophic factor, which supports neuronal growth, survival, and synaptic connectivity. ⁴⁵

Protection of Mitochondrial Function : Mitochondria, the energy powerhouses of cells, are highly susceptible to aging-related dysfunction. ⁴⁶ Phytochemicals like quercetin and catechins improve mitochondrial health by enhancing ATP production, reducing mitochondrial ROS, and stabilizing mitochondrial membranes. ⁴⁷ This helps maintain neuronal energy metabolism and prevents energy deficits in the aging brain.

Modulation of Neurotransmitter Systems : Neurotransmitters play a critical role in cognitive processes, and their dysregulation contributes to age-related cognitive decline. ⁴⁸ Several phytochemicals influence the activity of neurotransmitters, such as acetylcholine, dopamine, and serotonin, which play critical roles in cognition and mood. ³ For instance, compounds in Ginkgo biloba have been reported to enhance acetylcholine levels, improving memory and focus. ⁴⁹ The polyphenols in green tea, particularly catechins such as epigallocatechin gallate (EGCG), influence the synthesis, release, and activity of neurotransmitters like acetylcholine, dopamine, and serotonin. These specific polyphenols may enhance attention and memory by promoting neuroprotection, reducing oxidative stress, and modulating neurotransmitter signaling pathways. ⁵⁰ These effects can improve memory, attention, and mood.

Reduction of Amyloid and Tau Pathology : Some phytochemicals demonstrate the ability to mitigate amyloid-beta accumulation and tau hyperphosphorylation, key features of Alzheimer's disease. ⁵¹ For instance, resveratrol has been shown to reduce amyloid-beta aggregation and enhance its clearance, while curcumin inhibits tau phosphorylation and promotes autophagy.^52,53

Enhancement of Cerebral Blood Flow : Phytochemicals like anthocyanins and flavanols improve vascular function, enhancing blood flow to the brain. This supports oxygen and nutrient delivery, which are essential for maintaining cognitive function and preventing ischemic damage.^54,55

Key Phytochemicals with Cognitive Benefits

Numerous phytochemicals have demonstrated significant potential in preserving cognitive function and counteracting age-related decline. These phytochemicals highlight the vast potential of plant-based compounds in supporting brain health and mitigating age-related cognitive decline. However, realizing their full therapeutic potential requires addressing challenges such as bioavailability and dose optimization. Tables 1 and 2 below highlight some of the most well-researched phytochemicals, their plant sources, mode of action and clinical trial results.

Table 1.

Notable Phytochemicals, Their Plant Sources, Mode of Action and Clinical Trial Results.

S/N	Phytochemicals	Plant Sources	Mode of Action	Clinical Trial Results	Year of Study	Population Studied	References
1	General categories of flavonoids, eg, flavanones, anthocyanins, flavan-3-ols, flavonols, flavones, polymeric flavonoids,Polymeric flavonoids and proanthocyanidins	Fruits, vegetables, tea, and cocoa	Enhance synaptic plasticity, promote neurogenesis, and reduce oxidative stress	− Flavonoids intake (Flavanones, anthocyanin, and proanthocyanidins) was associated with improved cognition in longitudinal, cross-sectional and co-twin analyses. − Long-term Dietary Flavonoid Intake and Subjective Cognitive Decline in US Men and Women. Findings suggested that higher flavonoid intake may help preserve cognitive function in U.S. men and women.	2021	Healthy Human	56,57
2	Curcumin	Turmeric	Anti-inflammatory, antioxidant, and amyloid-reducing effects.	− Curcumin supplementation showed a positive effect on cognition via enhancing working memory. − Decreased brain inflammation and oxidative damage, thus improved memory and attention in older adults	2018	Healthy Human	58,59
3	Resveratrol	Grapes, red wine, and berries	Modulates inflammatory pathways, enhances mitochondrial function, and promotes amyloid-beta clearance. Example, including the inhibition of NF-κB and MAPK signaling, as well as the activation of SIRT1, which suppresses pro-inflammatory cytokine production	− Resveratrol supplementation improved cerebral blood flow, cerebral vasodilator responsiveness to hypercapnia and cognitive performance. − Regular resveratrol consumption improved cerebrovascular function and cognition in post-menopausal women, potentially reducing cognitive decline risk	2017, 2019	Healthy Human	60,61
4	Epigallocatechin Gallate	Mainly in in green tea, strawberries, red wine, grape seeds, apples.	− Strong antioxidant and anti-inflammatory properties − It supports mitochondrial function, and modulates neurotransmitter systems	− The consistent consumption of green tea correlated with enhanced cognitive performance in Chinese middle-aged and elderly individuals.	2022	Healthy Human	62
5	Quercetin	Apples, onions, and berries	Reduces oxidative stress, supports mitochondrial health, and enhances synaptic plasticity	– An enhancement in working memory and the inhibition of AChE, MAO-A, and MAO-B activities were noted, clearly illustrating the cognitive-enhancing effect of quercetin consumption.	2020, 2022, 2023	Animal/Healthy Human	63-65
6	Lutein and Zeaxanthin	Dark green leafy vegetables, corn, eggs, and avocados.	– Antioxidant and anti-inflammatory agent – Promotes visual and cognitive health	– Minimized cognitive decline, especially executive function. – Supplementation with lutein and zeaxanthin diminished eye strain and fatigue, while enhancing cognitive function, processing speed, attention, and visuospatial processing in children.	2019, 2021, 2024	Healthy Human	66-68
7	Ginsenosides	Ginseng	Enhances cholinergic function, promotes neurogenesis, and reduces neuroinflammation	– Ginseng supplementation improved cognitive performance, reaction time, and mental fatigue in healthy individuals and those with mild cognitive impairment (MCI).	2024	Healthy/Diseased Human	69,70
8	Bacopasides (from Bacopa monnieri)	Bacopa monnieri (Brahmi)	Enhances synaptic transmission, protects against amyloid-beta toxicity, and promotes antioxidant defense	– Bacopa monnieri supplementation led to significant improvements in memory, attention, and processing speed. – Shown to improve cognitive function in elderly individuals over a 12-week period.	2022, 2024	Healthy Human	71,72
9	Huperzine A	Huperzia serrata (Chinese club moss)	Inhibits acetylcholinesterase (AChE), increasing acetylcholine levels; has neuroprotective properties	– Improved cognitive performance in Alzheimer's patients by enhancing memory retention. – Shown to reduce oxidative stress and neuroinflammation.	2021	Diseased Human	73,74
10	Omega-3 Fatty Acids (DHA, EPA)	Fatty fish, flaxseeds, walnuts	Essential for neuronal membrane integrity, reduces neuroinflammation, and promotes synaptic plasticity	– Regular intake was associated with improved cognitive function and delayed cognitive decline in older adults. – Supplementation improved working memory and executive function in middle-aged and older populations.	2023	Healthy Human	75,76
11	Apigenin	Parsley, celery, chamomile	Enhances neurogenesis, reduces oxidative stress, and exhibits anti-inflammatory properties	– Apigenin consumption improved neurogenesis and synaptic function, leading to enhanced cognitive performance.	2020, 2024	Animal	77,78
12	Astaxanthin	Microalgae, salmon, shrimp	Strong antioxidant, reduces neuroinflammation, and protects against amyloid-beta accumulation	– Astaxanthin supplementation improved cognitive function and reduced oxidative stress markers in elderly individuals.	2022, 2023	Healthy Human	79,80
13	Fisetin	Strawberries, apples, onions, cucumbers	Stimulates autophagy, enhances neuroprotection, and improves synaptic plasticity	– Fisetin intake was associated with reduced cognitive decline in aging individuals.	2022, 2023	Animal/Healthy Human	81,82
14	Naringenin	Citrus fruits, tomatoes, grapefruit	Modulates neuroinflammation, enhances mitochondrial biogenesis, and protects against amyloid-beta toxicity	– Supplementation led to improved cognitive function and decreased neurodegeneration in preclinical models and early human trials.	2019, 2024	Animal/Healthy Human	83,84
15	Ellagic Acid	Pomegranates, berries, walnuts	Antioxidant, anti-inflammatory, and neuroprotective effects via modulation of amyloid-beta aggregation and tau pathology	– Clinical studies reported improved memory retention and protection against age-related cognitive decline.	2022, 2024	Healthy Human	85,86
16	Sulforaphane	Broccoli, Brussels sprouts, cabbage	Induces antioxidant response, detoxifies neurotoxic compounds, reduces neuroinflammation	– Enhanced cognitive resilience and reduced oxidative stress markers.	2022, 2025	Animal/Healthy Human	87,88
17	Caffeine	Coffee, tea, cacao	Enhances alertness, improves synaptic plasticity, reduces amyloid-beta aggregation	– Moderate coffee intake was associated with a lower risk of cognitive decline and Alzheimer's disease.	2021, 2023	Healthy Human	89,90
18	Lycopene	Tomatoes, watermelon, pink grapefruit	Strong antioxidant, reduces neuroinflammation, protects against neurodegenerative diseases	– Lycopene supplementation improved cognitive function and slowed cognitive decline in elderly individuals.	2020, 2024	Healthy Human	91,92
19	Genistein	Soybeans, soy products	Estrogenic effects, modulates neuroinflammation, promotes neurogenesis	– Associated with improved cognitive function in postmenopausal women.	2021, 2025	Healthy Human	93,94
20	Theobromine	Cocoa, dark chocolate	Enhances cerebral blood flow, neuroprotective, modulates neurotransmitter activity	– Cocoa flavonoids and theobromine improved cognitive performance, working memory, and mood.	2017, 2020	Healthy Human	95,96
21	Ergothioneine	Mushrooms	Antioxidant, reduces oxidative stress, protects against neurotoxicity	– Higher blood ergothioneine levels were associated with better cognitive function and lower risk of mild cognitive impairment.	2021, 2022	Healthy Human	97,98
22	Betanin	Beets	Improves cerebral blood flow, reduces oxidative stress, neuroprotective	– Beetroot juice supplementation improved oxygenation and cognitive performance in older adults.	2023, 2024	Healthy Human	99,100
23	Rosmarinic Acid	Rosemary, mint	Anti-inflammatory, reduces amyloid-beta aggregation, enhances cholinergic activity	– Improved cognitive function and memory retention in elderly individuals.	2022, 2024	Animal/Healthy Human	101,102
24	Diosgenin	Wild yam, fenugreek	Enhances neurogenesis, protects against oxidative stress, anti-inflammatory	– Diosgenin-rich extract improved memory and learning in aged individuals.	2020, 2024	Animal/Healthy Human	103,104
25	Galantamine	Snowdrop, daffodil	Acetylcholinesterase inhibitor, modulates neurotransmission, neuroprotective	– FDA-approved treatment for Alzheimer's, improves cognitive function and memory.	2023, 2024	Diseased Human	105,106

Table 2.

Some Phytochemicals, Biological Model Used, Route of Administration, and Reported Doses Used.

S/N	Phytochemicals	Human Studies	Animal (In Vivo) Studies	In Vitro Studies	Year of Study	Route of Administration	Reported Doses Used	Observed Therapeutic Effects	Population Studied	References
1	Flavonoids, eg, flavanones, anthocyanins, flavan-3-ols, flavonols, flavones, polymeric flavonoids,Polymeric flavonoids and proanthocyanidins	Yes	Yes	Yes	2021, 2020	Oral	Dietary intake; variable (200-1000 mg/day (humans), 10-100 mg/kg/day (rodents))	Antioxidant, anti-inflammatory, anti-cancer, neuroprotective	Healthy adults, rodents	107,108
2	Curcumin	Yes	Yes	Yes	2018	Oral	500-2000 mg/day (humans), 50-200 mg/kg/day (rodents)	Anti-inflammatory, anticancer, antioxidant, neuroprotective	Rodents	58,59
3	Resveratrol	Yes	Yes	Yes	2019, 2017	Oral	150-500 mg/day (humans), 10-100 mg/kg/day (rodents)	Anti-aging, antioxidant, anti-inflammatory, neuroprotective	Elderly adults, rodents	60,61
4	Epigallocatechin Gallate (EGCG)	Yes	Yes	Yes	2022	Oral	200-800 mg/day (humans), 25-100 mg/kg/day (rodents)	Antioxidant, anti-inflammatory, anti-cancer, neuroprotective	Healthy adults, rodents	62
5	Quercetin	Yes	Yes	Yes	2022	Oral	500-1000 mg/day (humans), 10-200 mg/kg/day (rodents)	Anti-inflammatory, antioxidant, antihypertensive	rodents	63
6	Lutein and Zeaxanthin	Yes	No	No	2021, 2019, 2024	Oral	6-20 mg/day (humans)	Eye health, antioxidant, neuroprotective effects	Adults with macular degeneration	66-68
7	Ginsenosides	Yes	Yes	Yes	2024	Oral	200-600 mg/day (humans), 10-50 mg/kg/day (rodents)	Neuroprotective, anti-inflammatory, anti-fatigue	Healthy adults, rodents	69,70
8	Bacopasides (from Bacopa monnieri)	Yes	Yes	Yes	2022, 2024	Oral	300-450 mg/day (humans), 40-80 mg/kg/day (rodents)	Cognitive enhancement, neuroprotective, anti-anxiety	Elderly adults with cognitive decline, rodents	71,72
9	Huperzine A	Yes	Yes	Yes	2021	Oral	200-400 μg/day (humans), 0.1-1 mg/kg/day (rodents)	Cognitive enhancement, neuroprotective	Alzheimer's patients, rodents	73,74
10	Omega-3 Fatty Acids (DHA, EPA)	Yes	No	No	2022, 2023	Oral	500-2000 mg/day (humans)	Cardiovascular health, anti-inflammatory, neuroprotective	Cardiovascular patients	75,76
11	Apigenin	Yes	Yes	Yes	2024, 2020	Oral	50-500 mg/day (humans), 10-50 mg/kg/day (rodents)	Anti-inflammatory, antioxidant, neuroprotective	Healthy adults, rodents	77,78
12	Astaxanthin	Yes	Yes	Yes	2023, 2022	Oral	4-12 mg/day (humans), 5-50 mg/kg/day (rodents)	Antioxidant, anti-inflammatory, anti-cancer	Healthy adults, rodents	79,80
13	Fisetin	Yes	Yes	Yes	2022, 2023	Oral	100-500 mg/day (humans), 10-50 mg/kg/day (rodents)	Antioxidant, anti-inflammatory, neuroprotective	Elderly adults, rodents	81,87
14	Naringenin	Yes	Yes	Yes	2019, 2024	Oral	50-500 mg/day (humans), 10-100 mg/kg/day (rodents)	Antioxidant, anti-inflammatory, lipid-lowering	Hyperlipidemic patients, rodents	83,84
15	Ellagic Acid	Yes	Yes	Yes	2024, 2022	Oral	400-800 mg/day (humans), 10-50 mg/kg/day (rodents)	Anti-cancer, antioxidant, anti-inflammatory	Cancer patients, rodents	85,86
16	Sulforaphane	Yes	Yes	Yes	2022, 2025	Oral	20-40 mg/day (humans), 10-50 mg/kg/day (rodents)	Anti-cancer, antioxidant, anti-inflammatory	Cancer patients, rodents	87,88
17	Caffeine	Yes	Yes	Yes	2021, 2023	Oral	100-400 mg/day (humans), 5-30 mg/kg/day (rodents)	Cognitive enhancement, anti-fatigue, anti-inflammatory	Healthy adults, rodents	89,90
18	Lycopene	Yes	Yes	Yes	2020, 2024	Oral	10-30 mg/day (humans), 10-50 mg/kg/day (rodents)	Antioxidant, anti-cancer, cardiovascular health	Cardiovascular patients, rodents	91,92
19	Genistein	Yes	Yes	Yes	2025, 2021	Oral	50-150 mg/day (humans), 10-100 mg/kg/day (rodents)	Anti-cancer, antioxidant, neuroprotective	Postmenopausal women, rodents	93,94
20	Theobromine	Yes	Yes	Yes	2020, 2017	Oral	250-500 mg/day (humans), 10-50 mg/kg/day (rodents)	Anti-inflammatory, cardiovascular health	Healthy adults, rodents	95,96
21	Ergothioneine	Yes	Yes	Yes	2022, 2021	Oral	5-30 mg/day (humans), 1-10 mg/kg/day (rodents)	Antioxidant, anti-inflammatory, neuroprotective	Healthy adults, rodents	97,98
22	Betanin	Yes	Yes	Yes	2024, 2023	Oral	20-50 mg/day (humans), 5-30 mg/kg/day (rodents)	Antioxidant, anti-inflammatory, liver protection	Patients with liver disorders, rodents	99,100
23	Rosmarinic Acid	Yes	Yes	Yes	2022, 2024	Oral	50-500 mg/day (humans), 10-50 mg/kg/day (rodents)	Antioxidant, anti-inflammatory, neuroprotective	Healthy adults, rodents	101,102
24	Diosgenin	Yes	Yes	Yes	2024, 2020	Oral	50-100 mg/day (humans), 10-50 mg/kg/day (rodents)	Anti-inflammatory, anti-cancer	Cancer patients, rodents	103,104
25	Galantamine	Yes	Yes	Yes	2023, 2024	Oral	8-24 mg/day (humans), 0.1-5 mg/kg/day (rodents)	Cognitive enhancement, neuroprotective	Alzheimer's patients, rodents	105,106,109

Challenges in Harnessing the Therapeutic Potential of Phytochemicals

Despite the promising cognitive benefits of phytochemicals, several challenges must be addressed to maximize their therapeutic potential. These obstacles pertain to the pharmacokinetics, formulation, and clinical application of these natural compounds.^110-112 Addressing these challenges requires interdisciplinary collaboration among researchers, clinicians, and industry stakeholders. Innovations in phytochemical research and formulation have the potential to unlock their full therapeutic potential, providing a natural and effective solution for combating age-related cognitive decline.

Bioavailability and Absorption : Many phytochemicals exhibit poor bioavailability due to limited absorption, rapid metabolism, and quick elimination from the body. ¹¹³ For example, compounds like curcumin and resveratrol have low water solubility and are extensively metabolized in the liver, resulting in minimal systemic circulation. ¹¹⁴ Enhancing their bioavailability is essential for achieving therapeutic efficacy.

Standardization of Doses : The concentration of phytochemicals in natural sources can vary widely depending on factors such as plant variety, growing conditions, and processing methods. ¹¹⁵ Standardized extraction and preparation methods are crucial to ensure consistent dosing in both research and clinical settings.

Formulation Challenges : Innovative delivery systems are needed to overcome the limitations of phytochemical stability and bioavailability. Techniques such as nanoencapsulation, liposomal formulations, and conjugation with carriers can improve solubility, stability, and targeted delivery to the brain. ¹¹⁶

Mechanistic Understanding : While many phytochemicals have demonstrated neuroprotective effects, the precise molecular mechanisms underlying their actions are not fully understood. More research is needed to delineate their interactions with cellular and molecular pathways, which can inform targeted therapeutic strategies.

Translation from Preclinical to Clinical Studies : Most evidence supporting the cognitive benefits of phytochemicals comes from preclinical studies in animal models or in vitro experiments. Clinical trials in humans often yield mixed results due to differences in study design, sample size, and dosage. ¹¹⁷ Conducting robust, large-scale clinical trials is essential for validating their efficacy in humans.^118,119

Potential Side Effects and Interactions: While phytochemicals are generally regarded as safe, excessive doses or long-term use may result in adverse effects or interact with conventional medications. ¹²⁰ For example, Ginkgo biloba has been linked to increased bleeding risk, particularly when used alongside anticoagulants, due to the action of ginkgolides (eg, ginkgolide B) as platelet-activating factor (PAF) antagonists that inhibit platelet aggregation.^121,122 However, a randomized controlled trial reported no significant impact of Ginkgo extract on haemostasis or bleeding risk, even in combination with acetylsalicylic acid or warfarin. ¹²³ Nonetheless, relying solely on Ginkgo biloba as an example is insufficient to support generalized claims about phytochemical safety. Other phytochemicals such as St. John's Wort (which can reduce the efficacy of drugs like cyclosporine and oral contraceptives via cytochrome P450 induction) and Ephedra (associated with cardiovascular complications) also illustrate the potential for significant drug-herb interactions.^124,125 These cases underscore the importance of evaluating each phytochemical on an individual basis regarding safety and interaction profiles.. Understanding the safety profile and contraindications of phytochemicals is vital for their clinical application.^126,127

Regulatory and Commercial Barriers : The regulatory classification of phytochemicals remains ambiguous, often positioning them between dietary supplements and pharmaceuticals. This regulatory gray area complicates approval processes and limits their integration into mainstream healthcare. ¹²⁸ Unlike synthetic drugs, phytochemicals are derived from natural sources, resulting in inherent variations in composition, bioavailability, and therapeutic effects. These variations pose challenges in standardizing formulations and ensuring consistent clinical outcomes. ¹²⁹ Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have established pathways for botanical drug approval. However, these frameworks remain complex and inconsistent across jurisdictions, leading to disparities in how phytochemicals are assessed and approved. ¹²⁸ The absence of globally harmonized regulatory standards further exacerbates these challenges, as differing criteria for safety, efficacy, and quality control create barriers to widespread clinical adoption. ¹²⁸

A critical limitation in current regulations is the lack of standardized quality control measures. Unlike synthetic pharmaceuticals, which undergo rigorous testing for purity and potency, phytochemicals often face variable manufacturing practices that affect their reproducibility and therapeutic reliability. Addressing this issue requires the development of clear, evidence-based regulatory guidelines that balance safety, efficacy, and accessibility.

Strengthening regulatory frameworks could facilitate more robust clinical research, ensure product consistency, and enhance public confidence in phytochemical-based therapeutics. By implementing standardized quality assurance protocols and fostering collaboration between regulatory agencies, researchers, and industry stakeholders, the path toward integrating phytochemicals into conventional medicine can be streamlined. A more structured regulatory approach would not only promote innovation in phytochemical research but also support their safe and effective use in healthcare.

Future Directions and Implications Toward Integrating Phytochemicals in Cognitive Health Strategies

Phytochemicals hold tremendous promise as a natural solution for mitigating age-related cognitive decline and enhancing brain health. By embracing these future directions, the field can move closer to integrating phytochemicals into comprehensive strategies for managing age-related cognitive decline. Their potential to offer a natural, multifaceted approach to brain health represents a transformative opportunity to improve the quality of life for aging populations worldwide. The emerging role of phytochemicals not only underscores their value as complementary therapies but also inspires further exploration of nature's vast pharmacological treasure trove. With ongoing advancements in science and technology, phytochemicals may soon become a cornerstone of strategies for promoting longevity and cognitive resilience. ¹³⁰ Below are some key future directions and implications for integrating phytochemicals into strategies for brain health:

Advancements in Delivery Systems : Continued innovation in delivery technologies, such as nanocarriers, liposomes, and hydrogels, will enhance the bioavailability and targeted action of phytochemicals. ¹³¹ These systems can enable controlled release, improved solubility, and efficient crossing of the blood-brain barrier, ensuring maximum therapeutic benefit. ¹³²

Personalized Nutrition and Precision Medicine : The integration of phytochemicals into personalized nutrition and precision medicine approaches offers a tailored solution for cognitive health. ¹³³ Genetic, metabolic, and lifestyle factors can be used to identify individuals who may benefit most from specific phytochemicals, ensuring targeted and effective interventions. ¹³⁴

Combination Therapies : Combining phytochemicals with existing pharmacological treatments or other natural compounds could provide synergistic effects, addressing multiple mechanisms of cognitive decline simultaneously. For instance, pairing antioxidant-rich phytochemicals with anti-inflammatory agents could offer enhanced neuroprotection. ¹³⁵

Integrative Approaches : Incorporating phytochemicals into holistic strategies that include diet, exercise, and cognitive training may yield the best outcomes for maintaining brain health. ¹³⁶ Diets rich in phytochemical-containing foods, such as the Mediterranean or MIND diets, already show evidence of cognitive benefits and could serve as models for integrative interventions. ¹³⁷

Expanding Research on Underexplored Compounds: While some phytochemicals, like flavonoids and curcumin, are well-researched, others remain underexplored. Expanding research into lesser-known compounds and their unique mechanisms of action could uncover new therapeutic opportunities.

Public Health and Education : Promoting awareness of the cognitive benefits of phytochemicals through public health campaigns and educational initiatives is essential. ¹³⁸ Encouraging the consumption of phytochemical-rich diets can empower individuals to take proactive steps toward preserving brain health as they age.

Policy and Regulatory Support : Developing clear regulatory frameworks for phytochemicals, including guidelines for safety, efficacy, and quality control, will facilitate their acceptance in mainstream healthcare. ¹³⁹ Policy support for research funding and public-private partnerships can accelerate innovation in this field.

Conclusion

The present review underscores the pivotal role of phytochemicals in modulating critical cellular pathways implicated in both aging and neurodegeneration. Bioactive compounds derived from natural sources particularly polyphenols, flavonoids, and alkaloids—have demonstrated significant neuroprotective effects by targeting oxidative stress, neuroinflammation, mitochondrial dysfunction, and impaired proteostasis. These hallmarks are common to both age-related cognitive decline and neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Importantly, phytochemicals contribute to the maintenance of neuronal integrity, synaptic plasticity, and cognitive resilience during aging, suggesting their potential as interventions to mitigate normal age-associated cognitive deterioration beyond their role in disease contexts.

Moreover, these compounds modulate key signaling pathways such as Nrf2-ARE, NF-κB, and AMPK/mTOR, which are intimately involved in cellular homeostasis and are dysregulated in both aging and disease states. Their influence on epigenetic processes—including DNA methylation and histone modifications further supports their capacity to regulate gene expression patterns critical for neuronal survival and cognitive function over the lifespan.

While many molecular mechanisms of aging-related cognitive decline overlap with those of neurodegenerative diseases, emerging evidence suggests that aging and pathological neurodegeneration may also involve distinct or amplified pathways. Understanding the extent to which phytochemicals can target these shared and divergent mechanisms is essential. Future research should aim to elucidate these variations, enhancing the specificity of phytochemical interventions for aging versus disease-modified brain function.

Although preclinical data provide compelling support for the neuroprotective properties of phytochemicals, translational challenges such as bioavailability, target specificity, and clinical efficacy persist. Therefore, future studies should prioritize comprehensive mechanistic investigations and rigorously designed clinical trials to validate the therapeutic utility of phytochemicals in age-related cognitive decline. In summary, phytochemicals represent a promising class of agents capable of modulating key molecular and epigenetic pathways involved in brain aging, offering a viable and multifaceted strategy to promote cognitive health and resilience in aging populations.